Citi Starts Mirum Pharamceuticals (MIRM) at Buy
Tweet
Share
E-mailGet Alerts MIRM Hot Sheet
Price: $98.97 +0.75%
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Citi analyst David Lebowitz initiates coverage on Mirum Pharamceuticals (NASDAQ: MIRM) with a Buy rating and a price target of $38.00.
For an analyst ratings summary and ratings history on Mirum Pharamceuticals click here. For more ratings news on Mirum Pharamceuticals click here.
Shares of Mirum Pharamceuticals closed at $24.98 yesterday.
You May Also Be Interested In
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Chardan Starts QumulusAI (QMLS) at Buy
- Piper Sandler Starts Mercury Systems (MRCY) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
